Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Ho

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|October 14, 2017
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIVPaul A Wender, Clayton T Hardman, Stephen Ho, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|November 8, 2025
Understanding the Canadian Interventional Radiology Landscape Through the Canadian Association of Interventional Radiology Database: A Descriptive StudyAnand Dhatt, Nevin de Korompay, Manraj K S Heran, et al.
Clinical and Translational Science|March 6, 2026
Early Development of Ocadusertib, a Selective Receptor-Interacting Serine/Threonine-Protein Kinase 1 InhibitorSimon J Shaw, Vanessa C Taylor, Jonathan T Sims, et al.
Journal of the National Cancer Institute|November 7, 2002
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinomaAnthony T C Chan, Y M Dennis Lo, Benny Zee, et al.
Head & Neck|September 11, 2003
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective studyBrigette B Y Ma, Terence C W Poon, K F To, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2003
A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinomaEdwin P Hui, Terence C W Poon, Peter M L Teo, et al.
Virology|May 26, 2018
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agentsMatthew D Marsden, Xiaomeng Wu, Sara M Navab, et al.
International Journal of Cancer|September 30, 2010
The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcomeStephen Ho Kin Chan, Josephine Mun Yee Ko, Kwok Wah Chan, et al.
Transplantation|July 14, 2007
The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim reportMichelle A Fung, Garth L Warnock, Ziliang Ao, et al.
Gut|October 10, 2020
Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistanceDominik Aschenbrenner, Maria Quaranta, Soumya Banerjee, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|October 14, 2017
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIVPaul A Wender, Clayton T Hardman, Stephen Ho, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|November 8, 2025
Understanding the Canadian Interventional Radiology Landscape Through the Canadian Association of Interventional Radiology Database: A Descriptive StudyAnand Dhatt, Nevin de Korompay, Manraj K S Heran, et al.
Clinical and Translational Science|March 6, 2026
Early Development of Ocadusertib, a Selective Receptor-Interacting Serine/Threonine-Protein Kinase 1 InhibitorSimon J Shaw, Vanessa C Taylor, Jonathan T Sims, et al.
Journal of the National Cancer Institute|November 7, 2002
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinomaAnthony T C Chan, Y M Dennis Lo, Benny Zee, et al.
Head & Neck|September 11, 2003
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective studyBrigette B Y Ma, Terence C W Poon, K F To, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2003
A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinomaEdwin P Hui, Terence C W Poon, Peter M L Teo, et al.
Virology|May 26, 2018
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agentsMatthew D Marsden, Xiaomeng Wu, Sara M Navab, et al.
International Journal of Cancer|September 30, 2010
The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcomeStephen Ho Kin Chan, Josephine Mun Yee Ko, Kwok Wah Chan, et al.
Transplantation|July 14, 2007
The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim reportMichelle A Fung, Garth L Warnock, Ziliang Ao, et al.
Gut|October 10, 2020
Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistanceDominik Aschenbrenner, Maria Quaranta, Soumya Banerjee, et al.
Pageof 5